Y-ART-3Alternative Names: Sulfated pentagalloyl glucose
Latest Information Update: 10 Sep 1998
At a glance
- Originator Yamanouchi
- Class Antivirals
- Mechanism of Action HIV fusion inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported HIV infections
Most Recent Events
- 10 Sep 1998 No-Development-Reported for HIV infections treatment in Japan (Unknown route)
- 25 Jun 1996 New profile
- 25 Jun 1996 Preclinical development for HIV infections treatment in Japan (Unknown route)